Organization Overview
Alternative names
anastrozole (arimidex) (3 trials)
autologous bone marrow (4 trials)
autologous hematopoietic cell (15 trials)
autologous mononuclear stem cell (1 trial)
bleomycin (blenoxane) (3 trials)
carmustine (bicnu) (10 trials)
cisplatin (platinol) (18 trials)
cyclophosphamide (cytoxan) (48 trials)
cytarabine (cytosar-u) (14 trials)
daratumumab (darzalex) (4 trials)
abemaciclib (verzenio) (1 trial)
abiraterone (zytiga) (1 trial)
acalabrutinib (calquence) (3 trials)
adenovirus type-5 vectored covid-19 vaccine (1 trial)
aflibercept (zaltrap) (4 trials)
aldesleukin (proleukin) (6 trials)
allogeneic hematopoietic stem cells (Hemacord) (16 trials)
allogeneic pancreatic islet cells (4 trials)
amifostine (ethyol) (2 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (3 trials)
arsenic trioxide (trisenox) (3 trials)
asparaginase (elspar) (1 trial)
atezolizumab (tecentriq) (4 trials)
autologous-allogeneic tandem hematopoietic stem cell (3 trials)
autologous cd19car-cd28-cd3zeta-egfrt-expressing tn/mem-enriched t-lymphocytes (3 trials)
azacitidine (vidaza) (2 trials)
basiliximab (simulect) (3 trials)
belinostat (beleodaq) (4 trials)
bevacizumab (avastin) (6 trials)
bicalutamide (casodex) (3 trials)
blinatumomab (blincyto) (2 trials)
brentuximab vedotin (adcetris) (9 trials)
busulfan (myleran) (12 trials)
cabozantinib (cometriq) (2 trials)
capecitabine (xeloda) (7 trials)
celecoxib (celebrex) (7 trials)
cetuximab (erbitux) (2 trials)
cholestyramine (questran) (1 trial)
clofarabine (clolar) (3 trials)
cmv-specific t-cells (2 trials)
cyclosporine (sandimmune) (5 trials)
dacarbazine (dtic-dome) (3 trials)
dasatinib (sprycel) (5 trials)
daunorubicin (cerubidine) (3 trials)
decitabine (dacogen) (5 trials)
degarelix acetate (firmagon) (2 trials)
dexrazoxane (zinecard) (2 trials)
docetaxel (taxotere) (8 trials)
doxorubicin (Doxil) (18 trials)
durvalumab (imfinzi) (3 trials)
erlotinib (tarceva) (5 trials)
estradiol (progynon depot) (1 trial)
exemestane (aromasin) (2 trials)
filgrastim (neupogen) (6 trials)
fludarabine (fludara) (22 trials)
fluorouracil (efudex) (12 trials)
ganciclovir (cytovene) (3 trials)
gemcitabine (gemzar) (17 trials)
gemtuzumab ozogamicin (mylotarg) (1 trial)
genetically engineered lymphocyte therapy (1 trial)
goserelin (zoladex) (4 trials)
hemopoietic stem cell (1 trial)
hydrocortisone (solu-cortef) (1 trial)
ibrutinib (imbruvica) (2 trials)
idarubicin (idamycin) (4 trials)
interferon alpha-2b (Intron-A) (4 trials)
leflunomide (arava) (8 trials)
lenvatinib (lenvima) (2 trials)
letermovir (prevymis) (1 trial)
leuprolide (lupron) (4 trials)
lmp-specific cytotoxic t-lymphocytes (2 trials)
mercaptopurine (purinethol) (3 trials)
modified vaccinia virus ankara vaccine expressing p53 (4 trials)
mogamulizumab (poteligeo) (2 trials)
multi-peptide cmv-modified vaccinia ankara vaccine (6 trials)
mycophenolate (myfortic) (7 trials)
nelfinavir (viracept) (1 trial)
nivolumab (opdivo) (12 trials)
oxaliplatin (eloxatin) (14 trials)
paclitaxel (taxol) (22 trials)
palbociclib (ibrance) (3 trials)
palifermin (kepivance) (4 trials)
pamidronate (aredia) (2 trials)
panitumumab (vectibix) (1 trial)
panobinostat (farydak) (3 trials)
pazopanib (votrient) (4 trials)
pembrolizumab (keytruda) (16 trials)
pemetrexed (alimta) (3 trials)
pertuzumab (perjeta) (2 trials)
plerixafor (mozobil) (3 trials)
polatuzumab vedotin (Polivy) (1 trial)
prednisone (meticorten) (6 trials)
ribociclib (kisqali) (1 trial)
romiplostim (nplate) (2 trials)
sipuleucel-t (provenge) (1 trial)
sirolimus (rapamune) (10 trials)
sorafenib (nexavar) (4 trials)
tacrolimus (prograf) (15 trials)
talazoparib (talzenna) (1 trial)
tamoxifen (nolvadex) (3 trials)
temsirolimus (torisel) (3 trials)
testosterone (delatestryl) (1 trial)
thalidomide (Thalomid) (3 trials)
topotecan (hycamtin) (7 trials)
trastuzumab (herceptin) (8 trials)
venetoclax (venclexta) (5 trials)
vinblastine (velban) (3 trials)
vincristine (oncovin) (4 trials)
vinorelbine (navelbine) (2 trials)
vorinostat (zolinza) (9 trials)
64cu-dota-daratumumab (1 trial)
7-hydroxystaurosporine (1 trial)
acetaminophen (tylenol) (1 trial)
allogeneic cd123car-cd28-cd3zeta-egfrt-expressing t-lymphocytes (1 trial)
allogeneic lymphocytes (1 trial)
autologous anti-psca-car-4-1bb/tcrzeta-cd19t-expressing t-lymphocytes (1 trial)
autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes (1 trial)
autologous cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t cells (2 trials)
autologous cd19/cd22 chimeric antigen receptor t-cells (1 trial)
autologous lymphocytes (2 trials)
bendamustine (treanda) (1 trial)
binimetinib (mektovi) (1 trial)
carboxylesterase-expressing allogeneic neural stem cells (2 trials)
carfilzomib (kyprolis) (1 trial)
cd19car-cd28-cd3zeta-egfrt-expressing tcm-enriched t-lymphocytes (2 trials)
cd28-cd3zeta-cd19t-expressing car t cells (1 trial)
cd4+ t-cell-depleted haploidentical hematopoietic cells (1 trial)
clostridium butyricum (3 trials)
copper cu-64-dota-alendronate (1 trial)
cpg-stat3 sirna cas3/ss3 (1 trial)
diphenhydramine (benadryl) (1 trial)
e. coli cd-expressing genetically modified neural stem cells (2 trials)
enasidenib (idhifa) (2 trials)
esomeprazole (nexium) (1 trial)
flucytosine (ancobon) (2 trials)
glasdegib (Daurismo) (1 trial)
il13ralpha2-specific hinge-optimized 41bb-co-stimulatory car truncated cd19-expressing autologous t-lymphocytes (2 trials)
il13ralpha2-specific, hinge-optimized, 41bb-costimulatory car/truncated cd19-expressing autologous t lymphocytes (1 trial)
il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells (Biological) (1 trial)
in 111-dota-basiliximab (1 trial)
indocyanine green (ic-green) (3 trials)
ipilimumab (yervoy) (4 trials)
isotretinoin (accutane) (1 trial)
ivosidenib (tibsovo) (1 trial)
ixabepilone (ixempra) (1 trial)
mirvetuximab soravtansine (1 trial)
mitoxantrone (novantrone) (2 trials)
necitumumab (portrazza) (1 trial)
neural stem cells-expressing crad-s-pk7 (1 trial)
oncolytic virus cf33-expressing hnis/anti-pd-l1 antibody (1 trial)
osimertinib (tagrisso) (1 trial)
pegaspargase (oncaspar) (1 trial)
pentostatin (nipent) (1 trial)
proanthocyanidin extract (1 trial)
regorafenib (stivarga) (1 trial)
ruxolitinib (jakafi) (2 trials)
temozolomide (temodar) (3 trials)
tetanus-cmv fusion peptide vaccine (2 trials)
tolerogenic dendritic cell vaccine (1 trial)
trametinib (mekinist) (1 trial)
trifluridine (viroptic) (1 trial)
alprostadil (prostin) (1 trial)
antihemophilic factor viii human (Hemofil M) (2 trials)
autologous umbilical cord blood (1 trial)
deferasirox (exjade) (1 trial)
dexmedetomidine (precedex) (1 trial)
fluconazole (diflucan) (1 trial)
fludeoxyglucose f-18 (3 trials)
Acute Disease (Phase 2)
Adenocarcinoma (Phase 2)
Adenocarcinoma, Bronchiolo-Alveolar (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Amyloidosis (Phase 2)
Anemia (Phase 2)
Anemia, Hemolytic (Phase 2)
Anemia, Hemolytic, Autoimmune (Phase 2)
Anemia, Refractory (Phase 2)
Anemia, Sickle Cell (Phase 1)
Astrocytoma (Phase 1)
Bile Duct Neoplasms (Phase 1)
Blast Crisis (Phase 2)
Brain Neoplasms (Phase 1)
Breast Carcinoma In Situ (Phase 3)
Breast Neoplasms (Phase 3)
Breast Neoplasms, Male (Phase 2)
Burkitt Lymphoma (Phase 2)
Calcinosis (Phase 1)
Carcinoma (Phase 3)
Carcinoma, Acinar Cell (Phase 1)
Carcinoma, Ductal, Breast (Phase 3)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma in Situ (Phase 3)
Carcinoma, Intraductal, Noninfiltrating (Phase 3)
Carcinoma, Lobular (Phase 3)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Carcinoma, Small Cell (Phase 1)
Carcinoma, Squamous Cell (Phase 2)
Carcinoma, Transitional Cell (Phase 2)
Central Nervous System Neoplasms (Phase 2)
Cholangiocarcinoma (Phase 1)
Chondrosarcoma (Phase 2)
Colonic Neoplasms (Phase 2)
Colorectal Neoplasms (Phase 2)
Cytomegalovirus Infections (Phase 2)
Desmoplastic Small Round Cell Tumor (Phase 2)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 2)
Disease (Phase 2)
Endometrial Neoplasms (Phase 2)
Enteropathy-Associated T-Cell Lymphoma (Phase 2)
Ependymoma (Phase 1)
Esophageal Neoplasms (Phase 2)
Esophageal Squamous Cell Carcinoma (Phase 2)
Fallopian Tube Neoplasms (Phase 2)
Fractures, Stress (Phase 2)
Gallbladder Neoplasms (Phase 1)
Glioblastoma (Phase 2)
Glioma (Phase 1)
Gliosarcoma (Phase 1)
Graft vs Host Disease (Phase 2)
Head and Neck Neoplasms (Phase 2)
Heart Failure (Phase 2)
Hemangiopericytoma (Phase 1)
Hematologic Diseases (Phase 2)
Hematologic Neoplasms (Phase 1)
Hemoglobinopathies (Phase 1)
Hemolysis (Phase 2)
Hepatitis C (Phase 4)
Hodgkin Disease (Phase 2)
Hypereosinophilic Syndrome (Phase 1)
Hyperplasia (Phase 3)
Immunoblastic Lymphadenopathy (Phase 2)
Infections (Phase 3)
Inflammatory Breast Neoplasms (Phase 2)
Intestinal Diseases (Phase 2)
Intestinal Neoplasms (Phase 2)
Intraocular Lymphoma (Phase 1)
Kidney Neoplasms (Phase 2)
Laboratory Infection (Phase 2)
Leukemia (Phase 2)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Erythroblastic, Acute (Phase 1)
Leukemia, Hairy Cell (Phase 2)
Leukemia, Large Granular Lymphocytic (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 2)
Leukemia, Megakaryoblastic, Acute (Phase 1)
Leukemia, Monocytic, Acute (Phase 1)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Accelerated Phase (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Leukemia, Plasma Cell (Phase 2)
Leukemia, Prolymphocytic (Phase 1)
Leukemia, Prolymphocytic, B-Cell (Phase 1)
Leukemia, Promyelocytic, Acute (Phase 2)
Leukemia, T-Cell (Phase 2)
Liposarcoma (Phase 2)
Liver Diseases (Phase 1)
Liver Neoplasms (Phase 2)
Lung Neoplasms (Phase 2)
Lymphadenopathy (Phase 2)
Lymphedema (Phase 2)
Lymphoma (Phase 3)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 1)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 3)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 1)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 3)
Lymphoma, T-Cell (Phase 2)
Lymphoma, T-Cell, Cutaneous (Phase 2)
Lymphoma, T-Cell, Peripheral (Phase 2)
Lymphomatoid Granulomatosis (Phase 1)
Lymphoproliferative Disorders (Phase 2)
Mastocytosis (Phase 2)
Mastocytosis, Systemic (Phase 2)
Medulloblastoma (Phase 1)
Melanoma (Phase 2)
Meningeal Neoplasms (Phase 1)
Meningioma (Phase 1)
Mesothelioma (Phase 2)
Multiple Myeloma (Phase 3)
Mycoses (Phase 2)
Mycosis Fungoides (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Neoplasm Metastasis (Phase 2)
Neoplasm, Residual (Phase 1)
Neoplasms (Phase 3)
Neoplasms, Germ Cell and Embryonal (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Neoplasms, Second Primary (Phase 1)
Nervous System Neoplasms (Phase 2)
Neuroblastoma (Phase 2)
Neuroectodermal Tumors, Primitive (Phase 1)
Neurotoxicity Syndromes (Phase 2)
Neutropenia (Phase 2)
Oligodendroglioma (Phase 1)
Osteosarcoma (Phase 2)
Ovarian Neoplasms (Phase 2)
Pancreatic Neoplasms (Phase 2)
Panniculitis (Phase 2)
Paraproteinemias (Phase 1)
Pelvic Neoplasms (Phase 2)
Penile Neoplasms (Phase 1)
Peritoneal Neoplasms (Phase 1)
Philadelphia Chromosome (Phase 2)
Plasmablastic Lymphoma (Phase 1)
Plasmacytoma (Phase 2)
Pleural Effusion (Phase 1)
Pleural Effusion, Malignant (Phase 1)
Polycythemia (Phase 1)
Polycythemia Vera (Phase 1)
Precancerous Conditions (Phase 2)
Preleukemia (Phase 2)
Primary Myelofibrosis (Phase 2)
Prostatic Neoplasms (Phase 2)
Rectal Neoplasms (Phase 2)
Recurrence (Phase 1)
Sarcoma (Phase 2)
Sarcoma, Ewing (Phase 2)
Scleroderma, Diffuse (Phase 1)
Scleroderma, Systemic (Phase 1)
Sclerosis (Phase 2)
Sezary Syndrome (Phase 2)
Skin Neoplasms (Phase 2)
Small Cell Lung Carcinoma (Phase 2)
Smoldering Multiple Myeloma (Phase 2)
Spinal Cord Neoplasms (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Stomach Neoplasms (Phase 2)
Syndrome (Phase 2)
Teratoma (Phase 2)
Testicular Neoplasms (Phase 3)
Thalassemia (Phase 1)
Thrombocythemia, Essential (Phase 1)
Thrombocytopenia (Phase 2)
Thrombocytosis (Phase 1)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Triple Negative Breast Neoplasms (Phase 2)
Ureteral Neoplasms (Phase 2)
Urethral Neoplasms (Phase 2)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 1)
Uterine Neoplasms (Phase 1)
Ventricular Remodeling (Phase 2)
Viremia (Phase 2)
Vitamin D Deficiency (Phase 2)
Waldenstrom Macroglobulinemia (Phase 1)